Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany  JAMA Intern Med. 2024;184(9):1002-1004
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39008326

Association between visceral adipose tissue and asthma based on the NHANES and Mendelian randomization study  Postgraduate Medical Journal. 2024;100(1187):642-648
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38538571

Association of Cellulitis With Obesity: Systematic Review and Meta-Analysis  JMIR Dermatol. 2024;7:e54302
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39163102

EHR Data Suggest Tirzepatide Outdoes Semaglutide for Weight Loss  JAMA. 2024;332(8):610
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39093576

Embracing the duality of BMI and central adiposity  Lancet. 2024;404(10455):824-825
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39216958

Excessive body weight in developmental coordination disorder: A systematic review and meta-analysis  Neuroscience and Biobehavioral Reviews. 2024;164:105806
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38986892

GLP-1 Agonists for Obesity  JAMA. 2024;332(8):673
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39083284

How do GLP-1 drugs work for weight loss . . . and everything else?  BMJ. 2024;386:q1767
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39159969

Hypertension in Obesity: Impact of Miscuffing in Blood Pressure Measurement  American Journal of Medicine. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39197718

Medications for Obesity: A Review  JAMA. 2024;332(7):571-584
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39037780

Nutrition, Obesity, and Seborrheic Dermatitis: Systematic Review  JMIR Dermatol. 2024;7:e50143
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39102684

Obesity and Associated Factors in Brazilian Adults: Systematic Review and Meta-Analysis of Representative Studies  International Journal of Environmental Research and Public Health. 2024;21(8)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39200634

Obesity in Adolescents: A Review  JAMA. 2024;332(9):738-748
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39102244

Obesity in adults  Lancet. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39159652

Obesity in Adults  JAMA. 2024;332(7):600
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39102238

Obesity in women giving birth in Victoria, 2010-2019: a retrospective cohort study  Medical Journal of Australia. 2024;221(3):162-168
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39010287

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial  Lancet. 2024;404(10454):773-786
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39181597

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity  JAMA Intern Med. 2024;184(9):1056-1064
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38976257

A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle  Curr Obes Rep. 2024;13(3):403-438
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38703299

Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial  JAMA. 2024;332(7):551-560
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38819983

Tirzepatide-New Evidence for the Treatment of Obesity From China  JAMA. 2024;332(7):536-538
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38819984

Weight Loss Drugs Linked With Lower Risk of 10 Cancers  JAMA. 2024;332(8):611
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39093581